Protocol Summaries: GSK1482160
| GSK Study ID |
Phase | Title | Status |
|---|---|---|---|
| 111383 | phase 1 | A First-Time-in-Human Randomised, Single Blind Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics, of Single Escalating Doses of GSK1482160, in Male and Female Healthy Subjects, and to make a preliminary assessment of the effect of food. | Completed |